^“Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells”. Journal of Immunology133 (1): 157–165. (July 1984).
PMID6586833.
^“A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow”. Leukemia Research9 (1): 1–9. (1985). doi:10.1016/0145-2126(85)90016-5.
PMID3857402.
^Tindle RW. Katz F. Martin H. Watt D. Catovsky D. Janossy G. Greaves M. (1987). “BI-3C5 (CD34) defines multipotential and lineage restricted progenitor cells and their leukaemic counterparts .”. In 'Leucocyte Typing 111: White Cell Differentiation Antigens. Oxford University Press, 654-655.
^Loken M. Shah V. Civin CI.. (1987). “Characterization of myeloid antigens on human bone marrow using multicolour immunofluorescence”. In: McMichael, Leucocyte Typing III:White Cell Differentiation Antigens.Oxford University Press 630-635.
^ ab“Novel functions of the CD34 family”. Journal of Cell Science121 (Pt 22): 3683–3692. (November 2008). doi:10.1242/jcs.037507.
PMID18987355.
^“Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis”. Immunologic Research34 (1): 13–32. (2006). doi:10.1385/IR:34:1:13.
PMID16720896.
^“Preferential induction of peripheral lymph node addressin on high endothelial venule-like vessels in the active phase of ulcerative colitis”. The American Journal of Gastroenterology102 (7): 1499–1509. (July 2007). doi:10.1111/j.1572-0241.2007.01189.x.
PMID17459027.
^“CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution”. Immunity22 (1): 43–57. (January 2005). doi:10.1016/j.immuni.2004.11.014.
PMID15664158.
^“The molecular basis of vascular lumen formation in the developing mouse aorta”. Developmental Cell17 (4): 505–515. (October 2009). doi:10.1016/j.devcel.2009.08.011.
PMID19853564.
^“Distinct requirements for optimal growth and In vitro expansion of human CD34(+)CD38(-) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells”. Blood94 (12): 4093–4102. (December 1999). doi:10.1182/blood.V94.12.4093.
PMID10590054.
^“Reconstitution of human haematopoiesis in non-obese diabetic/severe combined immunodeficient mice by clonal cells expanded from single CD34+CD38- cells expressing Flk2/Flt3”. British Journal of Haematology119 (2): 525–534. (November 2002). doi:10.1046/j.1365-2141.2002.03820.x.
PMID12406096.
^“Low rhodamine 123 retention identifies long-term human hematopoietic stem cells within the Lin-CD34+CD38- population”. Blood109 (2): 543–545. (January 2007). doi:10.1182/blood-2006-06-030270.
PMID16990597.
^“In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection”. Experimental Hematology21 (5): 614–622. (May 1993).
PMID8513861.
^“The endoglin(positive) sca-1(positive) rhodamine(low) phenotype defines a near-homogeneous population of long-term repopulating hematopoietic stem cells”. Immunity19 (4): 525–533. (October 2003). doi:10.1016/s1074-7613(03)00265-6.
PMID14563317.
^“Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience”. Cytotherapy13 (8): 993–999. (September 2011). doi:10.3109/14653249.2011.579961.
PMID21671823.
“The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses”. Laboratory Investigation; A Journal of Technical Methods and Pathology87 (9): 858–870. (September 2007). doi:10.1038/labinvest.3700654.
PMID17607298.
“Activated protein kinase C directly phosphorylates the CD34 antigen on hematopoietic cells”. The Journal of Biological Chemistry265 (19): 11056–11061. (July 1990). doi:10.1016/S0021-9258(19)38556-4.
PMID1694174.
“Structural and partial amino acid sequence analysis of the human hemopoietic progenitor cell antigen CD34”. Leukemia2 (12): 793–803. (December 1988).
PMID2462139.
“Two alternative forms of cDNA encoding CD34”. Experimental Hematology21 (2): 236–242. (February 1993).
PMID7678811. INIST:4784611.
“Generation and analysis of 280,000 human expressed sequence tags”. Genome Research6 (9): 807–828. (September 1996). doi:10.1101/gr.6.9.807.
PMID8889549.
“The characterization, molecular cloning, and expression of a novel hematopoietic cell antigen from CD34+ human bone marrow cells”. Blood89 (8): 2706–2716. (April 1997). doi:10.1182/blood.V89.8.2706.
PMID9108388.
“Peripheral blood-derived CD34+ progenitor cells: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV”. Journal of Immunology161 (8): 4169–4176. (October 1998).
PMID9780190.
“Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival”. Blood95 (3): 756–768. (February 2000). doi:10.1182/blood.V95.3.756.
PMID10648383.[リンク切れ]
“Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: a bicentric analysis of 299 leukaphereses”. Annals of Hematology80 (11): 639–646. (November 2001). doi:10.1007/s002770100365.
PMID11757722.
“Receptor-mediated endocytosis of CD34 on hematopoietic cells after stimulation with the monoclonal antibody anti-HPCA-1”. Journal of Hematotherapy & Stem Cell Research10 (6): 863–871. (December 2001). doi:10.1089/152581601317210953.
PMID11798512.